Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen Acquires Rapigene For Its SNP Analysis Tools

Premium

V

ENLO, Netherlands--Qiagen announced last week that it has acquired Rapigene, a maker of genomic and single-nucleotide polymorphism analysis technologies. Rapigene was a wholly owned subsidiary of Celltech Group of Bothell, Wash. The agreement called for Qiagen to issue 154,000 shares of its common stock, valued at $12 million, in exchange for 100 percent of outstanding equity in Rapigene.

Filed under

The Scan

Vaccine Update Recommended

A US Food and Drug Administration panel recommends booster vaccines be updated to target Omicron, CNBC reports.

US to Make More Vaccines for Monkeypox Available

The US is to make nearly 300,000 vaccine doses available in the coming weeks to stem the spread of human monkeypox virus, according to NPR.

Sentence Appealed

The Associated Press reports that Swedish prosecutors are appealing the sentence given to a surgeon once lauded for transplanting synthetic tracheas but then convicted of causing bodily harm.

Genome Biology Papers on COVID-19 Effector Genes, Virtual ChIP-seq, scDART

In Genome Biology this week: proposed COVID-19 effector genes, method to predict transcription factor binding patterns, and more.